Risky Business Part 2: SELECT’s Dirty Little Secret

Welcome to Part 2 of Novo Nordisk's masterful marketing push to turn their weight loss drugs into cardiovascular life savers. You can read Part 1 here. We'll start with an overview of the clinical trial at the centre of Novo's PR stunt, the 'Semaglutide Effects on...

Wegovy Is Coming…

It’s been quite some time since I wrote a blog - for most of this year I’ve been probing into the murky underworld of Big Pharma! This has been a HUGE sinkhole for time and emotional spoons, but alongside fabulous Fat Studies scholars Andrea Bombak & Patty Thille,...